Immunotherapy of hepatocellular carcinoma: recent progress and new strategyJiarui Li(Nanjing University of Chinese Medicine)Frontiers in ImmunologyMay 10, 202310.3389/fimmu.2023.1192506Cited by 34SaveCiteExport RISWatch citationsRelated PapersEfficacy and safety of surufatinib in patients with well-differentiated advanced extrapancreatic neuroendocrine tumors (NETs): Results from the randomized phase III study (SANET-ep)|Annals of Oncology|2019|17